Healthcare - Rebate reform could be just what the doctor ordered
In these four short videos Graham Doyle discusses why rebates have spiralled out of control in the US driving a bubble worth $150bn annually, why this is bad for patients, how the US government is set to tackle it and why this could actually be good for large cap pharma. Click here to read the latest research. Click the image below to watch the videos.
This communication is for use only by a person or entity that qualifies as a "Professional Client" or "Eligible Counterparty" within the meaning of the FCA's rules. It is therefore intended for use only by persons having professional experience in matters relating to investments. Any other person who receives this should not act on the contents. Disclaimer here.